From lab to luxury: AMSilk’s bioengineered yarns hit Balenciaga’s spring 2026 runway

August 10, 2026 |

In Germany, bioengineered yarns produced by biotech firm AMSilk GmbH have been featured in commercially available garments from Balenciaga’s Spring 2026 collection. The designs include a sharp-collared white shirt and a black shirtdress that cinches at the waist with a ribbon tie, complete with an embroidered tone-on-tone Balenciaga logo on one “gleaming-buttoned cuff.” Each style is available in select Balenciaga stores worldwide and on balenciaga.com.

“Seeing our material reach consumers through a global luxury brand is a defining moment for AMSilk,” Ulrich Scherbel, CEO, said in a press statement. “This application shows that bioengineered materials are no longer experimental. They are ready for demanding industrial environments and real market adoption. It reflects years of technological progress and demonstrates how innovation at material level can enable both performance and more resilient production systems.”

AMSilk’s advanced biomaterials are made from silk proteins and are 100% protein-based, fully biodegradable, and microplastic-free. 

Tags: ,

Category: Chemicals & Materials

Thank you for visting the Digest.

}